Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Synergy CHC Corp. (SNYR : NSDQ)
 
 • Company Description   
Synergy CHC Corp. is a provider of consumer health care, beauty and lifestyle products. The company's current brand portfolio consists of marquee brands, FOCUSfactor, a clinically-tested brain health supplement and Flat Tummy, a lifestyle and wellness brand which provides a suite of nutritional products to help women achieve their weight management goals. Synergy CHC Corp. is based in Westbrook, Maine.

Number of Employees: 21

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.86 Daily Weekly Monthly
20 Day Moving Average: 21,533 shares
Shares Outstanding: 11.25 (millions)
Market Capitalization: $20.93 (millions)
Beta: 3.48
52 Week High: $4.98
52 Week Low: $1.30
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.53% -0.37%
12 Week -20.17% -21.46%
Year To Date 0.00% 0.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
865 SPRING STREET
-
WESTBROOK,ME 04092
USA
ph: 207-321-2350
fax: -
snyr@gateway-grp.com http://www.synergychc.com
 
 • General Corporate Information   
Officers
Jack Ross - Chief Executive Officer and Chairman
Jaime Fickett - Chief Financial Officer
Alfred Baumeler - Director
J. Paul SoRelle - Director
Nitin Kaushal - Director

Peer Information
Synergy CHC Corp. (CHCR)
Synergy CHC Corp. (ESRX)
Synergy CHC Corp. (MYDP)
Synergy CHC Corp. (COR)
Synergy CHC Corp. (GBCS)
Synergy CHC Corp. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 87165D208
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 03/30/26
Share - Related Items
Shares Outstanding: 11.25
Most Recent Split Date: (:1)
Beta: 3.48
Market Capitalization: $20.93 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.04 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.31 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/30/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 6.00
Trailing 12 Months: 6.41
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 6.99
Price / Sales: 0.63
EPS Growth
vs. Year Ago Period: -90.00%
vs. Previous Quarter: -94.12%
Sales Growth
vs. Year Ago Period: 12.41%
vs. Previous Quarter: 18.93%
ROE
12/31/25 - -
09/30/25 - -19.51
06/30/25 - -18.56
ROA
12/31/25 - -
09/30/25 - 14.25
06/30/25 - 20.28
Current Ratio
12/31/25 - -
09/30/25 - 5.35
06/30/25 - 2.74
Quick Ratio
12/31/25 - -
09/30/25 - 4.79
06/30/25 - 2.41
Operating Margin
12/31/25 - -
09/30/25 - 7.77
06/30/25 - 10.02
Net Margin
12/31/25 - -
09/30/25 - 7.77
06/30/25 - 10.02
Pre-Tax Margin
12/31/25 - -
09/30/25 - 8.23
06/30/25 - 9.93
Book Value
12/31/25 - -
09/30/25 - -0.87
06/30/25 - -1.35
Inventory Turnover
12/31/25 - -
09/30/25 - 4.67
06/30/25 - 4.80
Debt-to-Equity
12/31/25 - -
09/30/25 - -
06/30/25 - -
Debt-to-Capital
12/31/25 - -
09/30/25 - -
06/30/25 - -
 

Powered by Zacks Investment Research ©